These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fenofibrate profiled as the fibrate with additional new data, supporting its use with statins in the European Medicines Agency recommendations. Cardiovasc J Afr; 2011; 22(1):55. PubMed ID: 21298212 [No Abstract] [Full Text] [Related]
5. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]]. Tomiyama H; Doba N Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101 [No Abstract] [Full Text] [Related]
7. After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes? Colhoun H Lancet; 2005 Nov; 366(9500):1829-31. PubMed ID: 16310536 [No Abstract] [Full Text] [Related]
8. [A meta-analysis on the safety of combination therapy with fenofibrate and statins]. Geng Q; Ren JY; Li SF; Chen H Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1063-8. PubMed ID: 24524615 [TBL] [Abstract][Full Text] [Related]
9. Effects of gemfibrozil conversion to fenofibrate on lipids in patients on statin therapy. Corbelli JC; Bullano MF; Willey VJ; Cziraky MJ; Corbelli ME; Waugh W Am J Cardiol; 2002 Dec; 90(12):1388-91. PubMed ID: 12480052 [No Abstract] [Full Text] [Related]
10. Statins: cholesterol, blood pressure and beyond. van Dokkum RP; Henning RH; de Zeeuw D J Hypertens; 2002 Dec; 20(12):2351-3. PubMed ID: 12473855 [No Abstract] [Full Text] [Related]
11. [Treatment of high blood cholesterol in patients with coronary heart disease]. Nagai Y; Yamashita S Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049 [No Abstract] [Full Text] [Related]
12. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose. Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927 [TBL] [Abstract][Full Text] [Related]
13. Beyond lipid lowering: the anti-hypertensive role of statins. Chopra V; Choksi PU; Cavusoglu E Cardiovasc Drugs Ther; 2007 Jun; 21(3):161-9. PubMed ID: 17468937 [TBL] [Abstract][Full Text] [Related]
14. The Conduit Artery Functional Endpoint (CAFE) study in ASCOT. Williams B; O'Rourke M; J Hum Hypertens; 2001 Aug; 15 Suppl 1():S69-73. PubMed ID: 11685915 [No Abstract] [Full Text] [Related]
15. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality? Dodson PM Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236 [TBL] [Abstract][Full Text] [Related]
16. [How to create cooperative patient for antihypertensive and hypolipidemic therapy]. Piťha J Vnitr Lek; 2017; 63(4):272-276. PubMed ID: 28520451 [TBL] [Abstract][Full Text] [Related]
17. [Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?]. Pérez A Endocrinol Nutr; 2010 Dec; 57(10):457-9. PubMed ID: 20688585 [No Abstract] [Full Text] [Related]
18. Severe hypertriglyceridaemia. Treatment with plasmapheresis. Izquierdo-Ortiz MJ; Abaigar-Luquin P Nefrologia; 2012 May; 32(3):417-8. PubMed ID: 22592440 [No Abstract] [Full Text] [Related]
19. Best medical treatment for a symptomatic carotid artery stenosis. Paraskevas KI; Mikhailidis DP; Veith FJ Lancet; 2011 Jan; 377(9760):123; author reply 123-4. PubMed ID: 21215879 [No Abstract] [Full Text] [Related]
20. Blood pressure-lowering drugs not considered as antihypertensives. Nilsson PM Curr Hypertens Rep; 2007 Aug; 9(4):249-50. PubMed ID: 17686371 [No Abstract] [Full Text] [Related] [Next] [New Search]